Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.

Cell | Jun 29, 2001

http://www.ncbi.nlm.nih.gov/pubmed/11439185

A putative G protein-coupled transmembrane polypeptide, named Pael receptor, was identified as an interacting protein with Parkin, a gene product responsible for autosomal recessive juvenile Parkinsonism (AR-JP). When overexpressed in cells, this receptor tends to become unfolded, insoluble, and ubiquitinated in vivo. The insoluble Pael receptor leads to unfolded protein-induced cell death. Parkin specifically ubiquitinates this receptor in the presence of ubiquitin-conjugating enzymes resident in the endoplasmic reticulum and promotes the degradation of insoluble Pael receptor, resulting in suppression of the cell death induced by Pael receptor overexpression. Moreover, the insoluble form of Pael receptor accumulates in the brains of AR-JP patients. Here, we show that the unfolded Pael receptor is a substrate of Parkin, the accumulation of which may cause selective neuronal death in AR-JP.

Pubmed ID: 11439185 RIS Download

Mesh terms: Acetylcysteine | Brain | Cell Death | Cells, Cultured | Cysteine Proteinase Inhibitors | Endoplasmic Reticulum | Humans | Ligases | Microscopy, Fluorescence | Parkinsonian Disorders | Precipitin Tests | Protein Binding | Protein Folding | Receptors, Cell Surface | Recombinant Fusion Proteins | Two-Hybrid System Techniques | Ubiquitin-Conjugating Enzymes | Ubiquitin-Protein Ligases | Ubiquitins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.